Superdrol inj
Superdrol Inj Dragon Pharma
Methasterone (Methyldrostanolone) 40 mg/mL · DHT-derived · non-aromatizing · injectable
Class
DHT-Derived · 17α-Methyl
Injectable AAS
Ester / Active Life
No ester
~24–36 h (oil depot)
Aromatization
None
No estrogen conversion
User Level
Advanced
hepatotoxic — liver monitoring required
Typical Dose
20–40 mg
per day
Injection Frequency
Daily or EOD
no ester — short depot
Cycle Length
4–6 weeks
PCT 3–5 days after last inj
Lab Tested
$95.00
$95.00
In Stock
Shipping
Superdrol Inj Dragon Pharma — Overview
Superdrol Inj Dragon Pharma is an injectable solution of methasterone (methyldrostanolone) at 40 mg/mL — a 17α-methylated, DHT-derived anabolic steroid in oil-based injectable form. Methasterone was originally marketed as a "legal" prohormone supplement before being classified as a Schedule III controlled substance. It delivers powerful lean mass and strength gains without any estrogenic activity, making it one of the driest and most potent mass agents in the Dragon Pharma injectable lineup available at Steroid Warehouse.
The injectable formulation bypasses the oral first-pass hepatic extraction, potentially reducing the peak hepatic concentration compared to the oral tablet form — but the 17α-methyl group is structurally intact, so hepatotoxicity is still a real concern and liver monitoring throughout the cycle is non-negotiable. This page covers the pharmacological basis for methasterone's potency, its effects and limitations versus comparable injectable compounds, and the liver-protective protocol required to run it safely.
Methasterone Methyldrostanolone 40 mg/mL DHT-Derived · 17α-Methyl Non-Aromatizing Lean Mass · Strength
On this page
About the Compound: Methasterone
Methasterone (2α,17α-dimethyl-5α-androstane-17β-ol-3-one) is structurally derived from drostanolone (Masteron) with an additional 2α-methyl group. This single structural addition dramatically amplifies androgen receptor binding affinity and anabolic potency while keeping androgenic activity relatively low on paper — though real-world androgenic side effects are still notable. Key structural features:
- 17α-methyl group — present in both the oral and injectable forms of Superdrol; provides resistance to hepatic degradation and is the source of hepatotoxicity; the injectable form avoids first-pass metabolism but the methyl group still reaches the liver via systemic circulation
- DHT backbone — does not interact with aromatase; no estradiol conversion; produces completely dry, water-free gains; no AI required
- 2α-methyl group — the key modification over drostanolone; significantly increases androgen receptor affinity and anabolic potency; the compound is already 5α-reduced (being a DHT derivative), so 5α-reductase inhibitors have no effect on its androgenicity
- Strong SHBG displacement — methasterone competes aggressively with SHBG, freeing more testosterone and other androgens in the system; this amplifies the effect of any testosterone base used alongside it
The injectable format at 40 mg/mL provides daily or every-other-day dosing without the digestive variability of oral tablets. Since there is no ester attached, the compound clears quickly — PCT can begin 3–5 days after the last injection.
Active Compound
Methasterone (Methyldrostanolone)
Concentration
40 mg/mL (10 mL vial = 400 mg)
Ester
None — oil-based depot
Active Life
~24–36 hours
Aromatization
None
Progestogenic
None
Hepatotoxicity
Yes — 17α-methyl group present
PCT start
3–5 days after last injection
Vials for 4-week cycle at 20 mg/day
2 vials (560 mg needed)
Vials for 6-week cycle at 20 mg/day
3 vials (840 mg needed)
What Superdrol Inj Does
- Rapid lean mass accumulation — methasterone drives significant muscle protein accretion via high-affinity androgen receptor activation; gains are lean and dry with no water retention because there is no estrogen conversion; users typically report 4–7 kg of lean tissue over a 4–6 week cycle, with a high proportion retained post-cycle compared to wet-bulk compounds
- Pronounced strength increases — strength gains with Superdrol are disproportionate to the volume of mass gained; the compound produces fast, dense neuromuscular strength improvements that make it a popular choice for strength sport athletes looking for rapid performance gains in a short window
- Muscle hardness and density — the absence of estrogenic water retention combined with DHT-derived drying effects produces a visually hard, dense, vascular physique; this characteristic makes Superdrol Inj suitable for pre-competition or finishing protocols as well as lean bulks
- SHBG suppression and androgen amplification — methasterone's aggressive SHBG displacement increases the free fraction of any co-administered testosterone, effectively amplifying the anabolic environment beyond what either compound alone would produce
- No estrogenic side effects — no aromatization means no gynecomastia risk from this compound, no estrogenic water retention, and no requirement for an aromatase inhibitor; however, the absence of estrogen at supraphysiologic androgen levels can negatively affect libido and joint comfort, particularly at higher doses
- HPG axis suppression — methasterone suppresses LH and FSH through androgen-mediated negative feedback; endogenous testosterone production is suppressed during the cycle; structured PCT is required
Who It's For
- What sets it apart: Superdrol Inj is the only injectable compound in the steroidwarehouse.com Dragon Pharma lineup that combines the anabolic potency of a 17α-methylated compound with the zero-estrogen profile of a DHT derivative. Other potent injectables either aromatize (Anadrol Inj, Dianabol Inj) or are much milder (Winstrol Inj, Masteron 100). The injectable form specifically offers more stable plasma levels than the oral with daily dosing, and avoids the GI variability of oral administration for users who find the oral form hard to tolerate digestively.
- Best scenario: advanced users targeting a short (4–6 week) lean bulk or strength peak with no tolerance for water retention or estrogenic sides; athletes in strength sports where weight-class management matters; experienced steroid users who have already run both an oral AAS cycle and a standard injectable testosterone cycle and understand liver monitoring; users who prefer injectable administration for all compounds in a stack for simplicity of management.
- Choose something else instead: users who have not run injectable AAS before should start with a testosterone base (Enantat 250) rather than an advanced methylated compound; anyone with elevated baseline liver enzymes (ALT/AST above normal range) should not use any 17α-methylated compound; users wanting longer bulk cycles (>8 weeks) should use a non-methylated compound such as Primobolan 100 or Deca 300; female users should avoid methasterone due to high virilization risk.
Superdrol Inj vs Alternatives
| Compound | Key Difference | Choose Superdrol Inj When | Choose Alternative When |
|---|---|---|---|
| Superdrol Dragon Pharma (oral) | Same active compound (methasterone 10 mg/tab); oral route involves first-pass hepatic metabolism creating higher peak liver concentrations; injectable form allows more precise daily dosing without GI involvement | You prefer injectable administration, want more stable plasma levels, or have GI sensitivity to oral Superdrol | You prefer oral convenience and do not have GI issues with the tablet form; the compounds are pharmacologically identical otherwise |
| Anadrol Inj Dragon Pharma | Oxymetholone-based injectable; similarly potent mass and strength agent; aromatizes moderately and is more estrogenic (wet gains, water retention); progestogenic risk; different hepatotoxicity profile | Your goal is completely dry, hard lean mass with no water retention and no need for an AI | You want maximum rapid mass gain and are comfortable managing estrogen; Anadrol Inj tends to produce larger scale gains when water retention is not a concern |
| Winstrol Injectable Dragon Pharma | Stanozolol; DHT-derived, non-aromatizing; much lower hepatotoxicity than methasterone; significantly milder anabolic effects; can be run for 8–10 weeks; lower strength/mass gains per unit dose | You want maximum potency and rapid lean mass in a short window and accept the liver monitoring requirement | You want a DHT-derived dry compound for a longer cycle (8–10 weeks) with lower liver risk and moderate hardening effects |
| Dianabol Injectable Dragon Pharma | Methandrostenolone injectable; 17α-methylated; aromatizes strongly and produces wet, full gains with water retention; comparable hepatotoxicity to Superdrol Inj; AI required | Dry, lean gains are the goal and you want no estrogen-related sides or AI management | You are in a mass-building phase where full glycogen-saturated appearance and estrogen-assisted recovery are acceptable or desirable; Dianabol Inj is better suited to pure size-focused bulks |
Combinations
| Goal | Stack | Notes |
|---|---|---|
| Lean bulk with testosterone base | Superdrol Inj 20 mg/day + Enantat 250 300–500 mg/week + liver support protocol | Standard approach: Enantat 250 provides the hormonal base and prevents the sexual dysfunction that can occur on Superdrol alone in a low-estrogen environment; run Superdrol Inj for weeks 1–4 while Enantat builds up; mandatory liver support throughout (Liv.52 + Mucinac or Ursocol) |
| Short-ester lean bulk (fast entry/exit) | Superdrol Inj 20 mg/day + Propionat 100 300–400 mg/week | All short-acting stack: Propionate esters clear in 3–4 days like Superdrol, so PCT can begin within 5–7 days of the last injection; suitable for users with time constraints or competition windows; EOD injections for both compounds; precise cycle-end control |
| Maximum hardness and density | Superdrol Inj 20 mg/day + Masteron 100 300–400 mg/week | Two DHT-derived non-aromatizing compounds; extreme dryness and vascularity; suited for final preparation stages or recomp at controlled body fat; monitor for joint discomfort in a low-estrogen environment at higher doses; no AI needed but monitor E2 if testosterone is included as the base |
| Lean bulk with minimal liver load | Superdrol Inj 20 mg/day (4 weeks only) + Primobolan 100 400–600 mg/week (12 weeks) | Superdrol Inj as a 4-week kickstart to a longer Primobolan base; Primobolan is non-methylated and mild on the liver; this keeps the hepatic stress window short while using Superdrol and transitions to a safer longer compound; liver enzymes should be tracked through the Superdrol phase and rechecked at week 6 |
| Strength peak (powerlifting / combat sport) | Superdrol Inj 20–30 mg/day + testosterone base (any ester) at maintenance dose | Methasterone's disproportionate strength-to-mass ratio makes Superdrol Inj highly effective for strength sport peak protocols; steroidwarehouse carries the full Dragon Pharma testosterone range to pair with it; keep cycle to 4 weeks maximum at 30 mg/day; mandatory ALT/AST check at week 2 and week 4 |
Side Effects & Management
| What May Occur | Background | How to Handle It |
|---|---|---|
| Hepatotoxicity (elevated ALT / AST) | The 17α-methyl group is present in injectable methasterone and reaches the liver via systemic circulation; unlike oral administration, first-pass extraction is avoided, but the compound is still processed hepatically; ALT/AST elevation is expected on any methasterone cycle and is the primary safety-limiting factor | Run liver support from day 1: Liv.52 2 tabs twice daily + Mucinac (NAC) 600 mg twice daily; add Ursocol (UDCA) 300 mg twice daily for its bile acid protective effect; check ALT/AST at week 2 and week 4; pause immediately if ALT exceeds 3× upper limit of normal; avoid alcohol throughout the cycle |
| Back pumps / muscle pumps | Superdrol-specific and very commonly reported; presents as painful cramping in the lower back erectors and other large muscle groups during training; mechanism is not fully characterized but likely related to SHBG displacement, intracellular water shifts within muscle, and altered electrolyte balance; not dangerous but can significantly impair training sessions | High-volume hydration (3–4 L water/day); taurine supplementation 3–5 g/day has strong user-reported efficacy; reduce training volume and rest times on compound lifts; if severe, reduce Superdrol Inj dose before other adjustments |
| Lethargy / fatigue | One of the most distinctive and commonly reported Superdrol sides; presents as persistent low energy, mental fatigue, and reduced motivation particularly in the afternoon; mechanism is unclear — possible cortisol pathway interaction or adrenal signaling changes; typically appears at 2–3 weeks into the cycle | Keep cycles short (4–6 weeks maximum); ensure adequate caloric intake — lethargy worsens significantly in a deficit; quality sleep and recovery; the fatigue resolves promptly after cycle end; dose reduction to 20 mg/day if 30–40 mg/day is being used and fatigue is impairing daily function |
| Cardiovascular — HDL suppression | 17α-methylated androgens strongly suppress HDL via hepatic lipase upregulation; methasterone has no estrogen to partially offset this suppressive effect on lipid profile; HDL can drop significantly, increasing cardiovascular risk during the cycle; this is compounded if stacking with other lipid-affecting compounds | Monitor lipids at baseline and end of cycle; Rosulip (Rosuvastatin) if LDL is elevated mid-cycle; omega-3 supplementation; limit saturated fat during the cycle; cardio 2–3×/week throughout; HDL typically recovers 4–6 weeks post-cycle |
| Blood pressure elevation | SHBG suppression and increased free androgen load contribute to BP elevation; more pronounced when stacked with testosterone at higher doses; the lack of estrogen removes one natural vasodilatory mechanism | Track BP weekly; target <130/85 mmHg; Sartel (Telmisartan) or Amlip (Amlodipine) if persistent elevation above 140/90; moderate-intensity cardio throughout the cycle |
| Androgenic — acne, hair loss | DHT-derived compound; does not 5α-reduce further (already 5α-reduced); finasteride has no effect on its androgenicity; acne and androgenic alopecia are determined by individual sensitivity to the compound itself | Topical protocols for acne; Accutane Dragon Pharma for severe/cystic acne; Minoxidil Dragon Pharma for hair retention; finasteride is not applicable here |
| Libido suppression / joint discomfort | No estrogen production means low E2 during a methasterone-only cycle or when testosterone dose is insufficient; low E2 causes reduced libido, potential ED, and joint dryness (cartilage requires estrogen for lubrication); always run an adequate testosterone base alongside Superdrol Inj | Maintain testosterone base at a dose sufficient to keep E2 in range (typically ≥200 mg/week testosterone); if running Superdrol Inj without exogenous testosterone (not recommended), monitor E2 and consider dose reduction if joints and libido deteriorate |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| ALT / AST (liver enzymes) | Baseline; week 2; week 4; end of cycle | Target ALT <40 U/L at baseline; on-cycle elevation of 1.5–2× ULN is common; immediately pause use if ALT exceeds 3× ULN (>120 U/L); this is the most critical monitoring parameter on any methasterone cycle |
| Lipid panel (HDL, LDL) | Baseline; end of cycle | HDL target >40 mg/dL; methylated AAS reliably suppress HDL; document baseline to measure true suppression; LDL target <130 mg/dL; lipids typically recover within 4–6 weeks post-cycle |
| Blood pressure | Baseline; weekly throughout cycle | Target <130/85 mmHg; weekly self-monitoring is adequate for most users; consistent readings above 140/90 warrant antihypertensive intervention |
| LH / FSH | Baseline; PCT week 4 | Expected to be suppressed to near-zero on cycle; recovery to >2 IU/L by PCT week 4 confirms HPG axis restart; short cycles (4–6 weeks) tend to recover faster than long AAS cycles |
| Hematocrit / CBC | Baseline; end of cycle | Target hematocrit <52%; general safety baseline; methylated androgens can stimulate erythropoiesis; documents pre-cycle status for post-cycle comparison |
| Total testosterone | Baseline (mandatory pre-cycle) | Documents natural testosterone level before any suppression; used as recovery target — post-PCT total testosterone should return to within 10–15% of pre-cycle baseline within 8–10 weeks of PCT completion |
PCT
Methasterone clears rapidly (no ester), so PCT timing is simpler than with long-ester compounds. HPG suppression from a 4–6 week methasterone cycle is generally less entrenched than after a 12–16 week testosterone cycle, supporting a standard SERM-based protocol without the mandatory HCG pre-load required for longer cycles.
| Phase | Protocol | Notes |
|---|---|---|
| PCT start | Begin 3–5 days after last Superdrol Inj injection | No ester means the compound clears within 1–2 days; wait 3–5 days to allow full clearance and any residual depot to dissipate before starting SERMs; if stacking with a long-ester testosterone base, PCT timing follows the longest ester (typically 21 days after last testosterone injection) |
| PCT weeks 1–4 | Nolvadex Dragon Pharma 40 mg/day weeks 1–2 → 20 mg/day weeks 3–4; or Clomid Dragon Pharma 50 mg/day weeks 1–2 → 25 mg/day weeks 3–4 | Single SERM is adequate for a 4–6 week methasterone cycle; Nolvadex is preferred for its favorable side effect profile; Clomid if LH/FSH recovery is slow at PCT week 2 check; dual SERM protocol only if prior bloodwork shows poor HPG recovery from previous cycles |
| HCG (optional) | HCG 5000 IU Dragon Pharma 500 IU EOD for 10 days before PCT, if cycle was 6 weeks or stacked with a long-ester testosterone | Not mandatory for a standalone 4-week Superdrol Inj cycle; consider adding HCG if stacking with testosterone ≥12 weeks, or if prior cycles have resulted in slow testicular recovery |
| Post-PCT bloodwork | Total testosterone, LH, FSH — 4–6 weeks after stopping SERMs | Target total testosterone recovery to within 10–15% of pre-cycle baseline; LH and FSH >2 IU/L confirms axis recovery; also recheck ALT/AST at this point to confirm liver enzyme normalisation |
Practical Summary
- Liver protection from day 1, not from when symptoms appear — Liv.52 + NAC (Mucinac) + UDCA (Ursocol) as a stack; ALT/AST check at week 2 is mandatory; pause immediately if ALT exceeds 3× upper limit of normal
- The 17α-methyl group is structurally present in the injectable form — injectable does not mean "liver-safe"; the route difference reduces first-pass exposure but does not eliminate hepatic processing
- Always run an adequate testosterone base alongside Superdrol Inj; the no-estrogen environment without exogenous testosterone causes libido suppression, joint dryness, and can impair recovery; Enantat 250 or Propionat 100 are the standard bases
- Back pumps and lethargy are Superdrol-specific and almost universal at effective doses; taurine 3–5 g/day is the most effective counter for back pumps; lethargy resolves promptly post-cycle
- Maximum 6 weeks; do not extend trying to outrun the liver window — the risk-to-benefit ratio deteriorates sharply beyond week 6 without evidence of additional gains
- PCT starts 3–5 days after last injection (no ester); Nolvadex 40/20 for 4 weeks; recheck ALT/AST and total testosterone 4 weeks after PCT completion
Superdrol Inj Dragon Pharma occupies a distinct position in the injectable AAS lineup — delivering the lean, dry, strength-focused results of a potent methylated compound without the digestive variability of the oral form and with more stable daily plasma levels. For advanced users running short focused cycles who prioritize dense, water-free lean mass and rapid strength gains, it is one of the most effective tools steroidwarehouse.com carries in the Dragon Pharma injectable range. The trade-off is an uncompromising liver monitoring requirement and a firm 4–6 week maximum duration; respecting those limits and running the full liver support protocol keeps the risk profile manageable.
References
| Source | Topic | Link |
|---|---|---|
| New England Journal of Medicine / PubMed | Bhasin et al. 1996 — randomized controlled trial using 600 mg/week testosterone enanthate for 10 weeks, showing increased fat-free mass, muscle size, and strength, especially when combined with resistance training; foundational evidence for supraphysiologic androgen anabolic effects | Bhasin S, et al. (1996) ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — synthetic testosterone-derived AAS pharmacology, androgen receptor mechanism, anabolic-androgenic effects, oral and injectable steroid classes, misuse patterns, monitoring, and adverse effect profile | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — testosterone and androgen derivative mechanisms of action, androgen receptor activity, HPG axis suppression, 5α-reduction, estradiol aromatization, synthetic androgen pharmacology, and androgen misuse context | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
| Seminars in Liver Disease / PubMed | Ishak & Zimmerman 1987 — hepatotoxic effects of anabolic-androgenic steroids; covers liver injury patterns linked to 17α-alkylated androgens, including cholestasis, peliosis hepatis, hepatic adenoma, and other steroid-related liver complications | Ishak KG & Zimmerman HJ (1987) ↗ |
| Journal of Clinical Gastroenterology / PubMed | Singh et al. 2009 — methasterone-specific case report describing severe hepatotoxicity caused by a methasterone-containing performance-enhancing supplement; directly relevant to methasterone/Superdrol liver-risk discussion | Singh V, et al. (2009) ↗ |
What is Superdrol Inj?
Superdrol Inj is an injectable anabolic steroid (Methyldrostanolone) for muscle growth; see What is Superdrol Inj. It's highly potent—consult professionals for safe use.
Is there anything stronger than Superdrol Inj?
Compounds like Trenbolone or Methyltrienolone may be stronger but riskier; see Is There Anything Stronger Than Superdrol Inj. Consult professionals for alternatives.
How does Superdrol Inj work?
It binds androgen receptors to promote muscle growth and strength; see Mechanism of Action. It delivers rapid gains—monitor with labs.
Is Superdrol Inj safe?
It's safe with strict dosing and monitoring; see Side Effects. Manage risks with PCT—consult professionals for safety.
What is Superdrol Inj used for?
It's used for rapid muscle growth and strength in bulking; see Key Benefits. It suits advanced users—use with professional oversight.
How long does it take to notice effects from Superdrol Inj?
Many users report noticeable improvements in strength, muscle fullness, and workout performance within a relatively short period due to the potent nature of the compound.
What are the main benefits of Superdrol Inj?
Commonly reported benefits include rapid strength gains, increased muscle density, enhanced lean mass development, improved recovery, and a harder physique appearance.
Is Superdrol Inj better for bulking or cutting?
Superdrol Inj is most commonly associated with lean bulking and recomposition phases because of its reputation for promoting quality muscle gains with minimal water retention.
Related Products
Available Domestic
Lab Tested
Anadrol Inj Dragon Pharma
Oxymetholone 50 mg/ml · DHT-derived injectable · non-aromatizing via aromatase
Class
DHT-Derived
Injectable AAS
Ester / Active Life
No ester
~8–16 hours
Aromatization
None
No estrogen via aromatase
User Level
Intermediate
to Advanced
Typical Dose
50–100 mg
per day
Injection Frequency
Daily
short active life
Cycle Length
4–6 weeks
typical range
Lab Tested
Cagrilintide Dragon Pharma
Long-acting amylin analogue · calcitonin receptor agonist · 10 mg vial
Category
Amylin Analogue
Weight management peptide
Form / Strength
Lyophilized vial
10 mg · reconstitute before use
Context
Appetite suppression
weight loss · metabolic support
Administration
SC injection
once weekly
Starting Dose
0.3 mg
per week
Target Dose
2.4–4.5 mg
16-week titration
Duration
Long-term
maintenance after titration
Available Domestic
Lab Tested
Clenbuterol Dragon Pharma
Beta-2 adrenergic agonist · thermogenic · 40 mcg per tablet
Category
Beta-2 Agonist
Thermogenic / fat loss
Form / Strength
Oral tablet
40 mcg per tab
Context
Fat loss · cutting
metabolic rate increase
Monitoring
Heart rate
blood pressure · tremors
Starting Dose
40 mcg/day
increase by 20 mcg every 2–3 days
Peak Dose
80–160 mcg
men · women: 40–100 mcg
Protocol
2 wk on
2 wk off · or with ketotifen
Lab Tested
Cut Long 300 Dragon Pharma
Test E 100 · Tren E 100 · Masteron E 100 · 300 mg/ml
Category
Injectable AAS Blend
3-compound / long esters
Composition
300 mg/ml total
Test E · Tren E · Drost E
Context
Cutting · Recomp
lean mass · fat loss · density
Administration
IM injection
once or twice weekly
Typical Dose
300–600 mg
per week
Frequency
1–2× / week
long ester schedule
Cycle Length
10–16 weeks
PCT ~2 wks after last inj
Available Domestic
Lab Tested
Deca-500 Dragon Pharma
Nandrolone Decanoate · 500 mg/ml
Class
Anabolic Steroid
19-nor testosterone derivative
Half-life
~15 days
decanoate ester, weekly dosing
Context
Bulking · Joints
high-dose, low injection volume
Administration
IM injection
weekly or E5D
Typical Dose
400–600 mg/wk
always with testosterone base
Frequency
Weekly / E5D
stable long-ester levels
Cycle Length
12–16 weeks
PCT 3 weeks after last pin
Available Domestic
Lab Tested
EQ 200 / Test E 200 Dragon Pharma
Boldenone Undecylenate 200 mg/mL + Testosterone Enanthate 200 mg/mL · pre-mixed blend
Class
Dual-Compound Blend
Boldenone + Test Enanthate
Ester / Active Life
Undecylenate + C8
~14 day EQ t½ · ~4.5 day Test t½
Aromatization
Moderate
AI recommended on-cycle
User Level
Intermediate
to Advanced
Typical Dose
400–800 mg
blend per week
Injection Frequency
E3.5D or E7D
twice or once weekly
Cycle Length
12–16 weeks
PCT 21 days after last pin
Available Domestic
Lab Tested
EQ 300 Dragon Pharma
Boldenone Undecylenate 300 mg/mL · long-ester injectable · requires testosterone base
Class
Testosterone Derivative
Injectable AAS
Ester / Active Life
Undecylenate (C11)
~14-day active half-life
Aromatization
Low to Moderate
~50% of testosterone per mg
User Level
Intermediate
to Advanced
Typical Dose
300–600 mg
per week
Injection Frequency
E3.5D or E7D
twice or once weekly
Cycle Length
12–16 weeks
PCT 21 days after last pin
Available Domestic
Lab Tested
Melanotan II Dragon Pharma
Melanocortin receptor agonist · sunless tanning & libido peptide · 10 mg vial
Category
Melanocortin Agonist
α-MSH cyclic analogue
Form / Strength
Lyophilized vial
10 mg · reconstitute before use
Context
Tanning & libido
sunless tan · sexual function
Administration
SC injection
daily loading · maintenance as needed
Loading Dose
0.5–1 mg
per day
Maintenance
0.5 mg
2–3× per week
Tan Onset
1–2 weeks
with UV exposure